Use the Back button in your browser to see the other results of your search or to select another record.
Effect of six months of aerobic exercise on plasma interleukin-6 and tumor necrosis factor-alpha as breast cancer risk factors in postmenopausal women: a randomized controlled trial |
Abdollahpour A, Khosravi N, Eskandari Z, Haghighat S |
Iranian Red Crescent Medical Journal 2017 Jan;19(1):e27842 |
clinical trial |
5/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
BACKGROUND: Increased physical activity is associated with a reduction in the risk of breast cancer; however, the exact mechanism of the reduction is not yet completely known. OBJECTIVES: This study aimed to investigate the effect of six months of aerobic exercise on the plasma interleukin (IL)-6 and tumor necrosis factor-alpha (TNF-alpha) levels as breast cancer risk factors in postmenopausal women. Patients and METHODS: This study was a randomized controlled trial. We randomly assigned 41 postmenopausal, sedentary women aged 50 to 74 to either an exercise or a control group. The intervention involved facility-based aerobic exercise (three days/week, at 70 to 80% of the maximum heart rate, for six months). RESULTS: Twenty-seven women completed the study. The plasma IL-6 level decreased by 21.3% in the exercisers and by 6.9% in the controls, and the intervention effect was significant (p = 0.001). The plasma TNF-alpha level decreased by 17.1% and 10.8% in the exercisers and controls, respectively, although the effect of exercise was not statistically significant (p = 0.28). Overall, long-term aerobic exercise may result in a decreased IL-6 concentration. CONCLUSIONS: We suggest that regular aerobic exercise can favorably alter the inflammatory profile, which is a known risk factor in breast cancer development, in postmenopausal women.
|